Indegene Ltd Cash Flow Conversion Efficiency
Indegene Ltd cash flow conversion efficiency. Based on the latest financial reports, Indegene Ltd (INDGN) has a cash flow conversion efficiency ratio of 0.071x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs2.03 Billion ≈ $21.93 Million USD) by net assets (Rs28.66 Billion ≈ $309.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Indegene Ltd (2020–2026)
Cash flow conversion efficiency of Indegene Ltd from 2020 to 2026. This chart illustrates how Indegene Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Indegene Ltd for real-time trading data and today's change.
Indegene Ltd Cash Flow Conversion Ratio Explained
Indegene Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Indegene Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Indegene Ltd ranked by their cash flow conversion efficiency. Also see Indegene Ltd market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Vietnam National Petroleum Group
VN:PLX
|
0.325x |
|
Live Oak Bancshares, Inc.
NYSE:LOB
|
0.090x |
|
GS Engineering & Construction
KO:006360
|
0.011x |
|
Bayer Cropscience Limited
NSE:BAYERCROP
|
-0.012x |
|
Compania Nationala de Transport al Energiei Electrice Transelectrica SA
RO:TEL
|
0.054x |
|
Harbin Boshi Automation Co Ltd
SHE:002698
|
0.010x |
|
Telecom Argentina
BA:TECO2
|
0.156x |
|
Golden Ocean Group Ltd
NASDAQ:GOGL
|
-0.002x |
Annual Cash Flow Conversion Efficiency for Indegene Ltd (2020–2026)
The table below shows the annual cash flow conversion efficiency of Indegene Ltd from 2020 to 2026. Review INDGN free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs31.39 Billion ≈ $339.44 Million |
Rs6.63 Billion ≈ $71.74 Million |
0.211x | +25.10% |
| 2025-03-31 | Rs26.16 Billion ≈ $282.87 Million |
Rs4.42 Billion ≈ $47.79 Million |
0.169x | -52.44% |
| 2024-03-31 | Rs14.29 Billion ≈ $154.55 Million |
Rs5.08 Billion ≈ $54.91 Million |
0.355x | +190.20% |
| 2023-03-31 | Rs10.64 Billion ≈ $115.04 Million |
Rs1.30 Billion ≈ $14.08 Million |
0.122x | -68.52% |
| 2022-03-31 | Rs7.64 Billion ≈ $82.61 Million |
Rs2.97 Billion ≈ $32.12 Million |
0.389x | -24.71% |
| 2021-03-31 | Rs3.33 Billion ≈ $36.02 Million |
Rs1.72 Billion ≈ $18.60 Million |
0.516x | +136.17% |
| 2020-03-31 | Rs-155.98 Million ≈ $-1.69 Million |
Rs222.73 Million ≈ $2.41 Million |
-1.428x | -- |
About Indegene Ltd
Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It al… Read more